When Fangzhou Inc. and Fosun Pharma announced their strategic alliance this week to deliver "AI-powered psoriasis management," they joined dozens of healthcare AI ventures claiming to revolutionize patient care through technology. But buried in that announcement is a crisis no one's talking about: these platforms are building sophisticated AI systems that patients fundamentally cannot communicate with effectively, creating a structural barrier to the very behavior change these interventions require.

This isn't about whether the AI works—it's about whether patients can actually use it to manage chronic disease.

The Hidden Protocol Mismatch in Healthcare AI

Here's what Fangzhou's announcement reveals about healthcare's Application Layer Communication problem: they're building AI agents that monitor symptoms, recommend treatments, and track adherence. But chronic disease management requires sustained, nuanced dialogue between patient and system—explaining symptom context ("the rash appeared after eating shellfish"), negotiating treatment trade-offs ("this medication helps but the side effects make work impossible"), and articulating barriers to adherence ("I can't afford the co-pay this month").

This is Application Layer Communication at its most demanding: orchestrating AI agents through structured input to achieve health outcomes. Yet healthcare companies are shipping these platforms to populations with no training in how to communicate effectively with AI systems.

The British Standards Institution's warning this week about the "looming AI governance crisis" captures half the problem—business leaders aren't managing AI risk. But they're missing the deeper issue: we're deploying AI systems that require advanced communication literacy to populations we haven't trained to use them.

The Organizational Theory Failure Mode

Polychroniou's recent research on cross-functional conflict management offers an unexpected lens here. His work shows that interdepartmental failures stem from misaligned communication protocols—teams speaking different "languages" while believing they're aligned.

Healthcare AI platforms replicate this failure mode at scale. Product teams build systems optimized for technical capability ("our AI can detect psoriasis flare patterns with 94% accuracy"). Medical teams evaluate clinical efficacy ("does this improve PASI scores?"). But no one's asking the critical organizational question: what communication competencies must patients possess to actually extract value from this system?

This matters because psoriasis isn't just a medical condition—it's an organizational challenge where the patient becomes their own care coordinator, integrating inputs from dermatologists, primary care, insurance systems, pharmacies, and now AI platforms. Fangzhou's technology adds another node to this coordination burden without addressing the fundamental communication skills gap.

Why This Differs From Consumer AI

When ChatGPT launched, users could experiment playfully with prompting techniques. Get a bad response? Try rephrasing. The stakes were low, the learning curve gentle.

Healthcare AI operates under fundamentally different constraints. A psoriasis patient who can't effectively communicate symptom patterns to the AI might receive inappropriate treatment recommendations. Someone who doesn't understand how to structure queries about medication interactions might make dangerous decisions. The consequences of poor Application Layer Communication aren't frustrating—they're potentially harmful.

Yet healthcare AI companies are treating patient communication literacy as someone else's problem. Fangzhou's announcement mentions AI capabilities extensively but says nothing about patient training, communication scaffolding, or literacy development.

The Strategic Blindness

Here's the uncomfortable truth: healthcare AI platforms will fail not because the technology is inadequate, but because they're building sophisticated communication systems for populations unable to communicate with them effectively. It's like distributing smartphones to users who've never learned to read—the device works perfectly, but the prerequisite literacy doesn't exist.

Katsoni and Sahinidis's work on innovation adoption in Greek tourism shows that technology implementation fails when organizations don't account for contextual variables affecting adoption. Healthcare AI is making this mistake systematically: assuming that clinical efficacy alone drives adoption, ignoring the communication competency prerequisites.

The Fangzhou-Fosun partnership will likely produce impressive clinical trial data showing AI-driven symptom monitoring improves outcomes in controlled environments. But real-world effectiveness will crater when patients can't structure queries, can't interpret AI responses accurately, and can't maintain the sustained dialogue these systems require.

Until healthcare AI companies recognize Application Layer Communication as a prerequisite competency—not an assumed capability—they're building castles on sand. The AI works. The patients just can't talk to it.